At the @EuroRespSoc Congress 2025, we shared structural & mechanistic data driving verekitug’s potency through TSLP receptor targeting. Data support the MOA’s potential for differentiated therapeutic effect in severe #asthma, #COPD & #CRSwNP. Learn more: investors.upstreambio.com/news-releases/…
Attending the @EuroRespSoc 2025 in Amsterdam? Don’t miss our presentation on Tuesday, Sept 30, at 10:15 CEST, further elucidating mechanistic drivers of verekitug’s potent pharmacodynamic activity through its unique TSLP receptor-targeting approach: bit.ly/4mEVg0f
Today on #WorldLungDay, Upstream is proud to support the @FIRS_LungsFirst and efforts to raise awareness of the importance of lung health, which is crucial to help improve the lives of patients with chronic respiratory diseases. Learn more: bit.ly/46THstP
Join us today as our CEO, Rand Sutherland, MD, participates in a fireside chat at the @Stifel 2025 Virtual Immunology and Inflammation Forum at 10:30 a.m. EDT. Watch live or catch the replay on our website: bit.ly/46mliim
Join us at the @Stifel 2025 Virtual Immunology and Inflammation Forum where our CEO, Rand Sutherland, MD, will participate in a fireside chat on September 15th at 10:30 AM ET. Tune in live or watch the replay on our website. Learn more here: bit.ly/47BYjT2
Today, we announced we’ll be hosting a webcast tomorrow morning at 8:00 am ET to report top-line data from the Phase 2 VIBRANT trial of #verekitug in patients with #CRSwNP. Learn more about how you can join the webcast live or listen to a replay here: bit.ly/4p3mBLQ
The perfect way to wrap up the summer, an outing at Top Golf! From friendly competition to some hole-in-onemoments, we had a blast. Check out these pics to see how we keep the team spirit going strong both on and off the course. #TeamBuilding
Today, we shared financial results for the second quarter of 2025, highlighting our clinical progress on track for top-line data anticipated from our Phase 2 trial in #CRSwNP in Q3 of 2025 and our Phase 2 trial in severe #asthma in Q1 of 2026. Learn more: bit.ly/3J4aMEH
Today, we announced first patient dosed in our global Phase 2 trial, VENTURE, in moderate-to-severe #COPD, marking our third pipeline indication in severe #respiratorydiseases.
In #asthma, we now expect top-line data in Q1 of 2026.
Learn more: bit.ly/44Bxg6S
Proud to have joined the global immunology community at @EAACI_HQ Annual Congress 2025. Thanks to all who attended our presentation supporting mechanistic insights to #Verekitug’s enhanced potency via its TSLP receptor targeting. #ICYMI: View poster here: upstreambio.com/science/
At @EAACI_HQ Annual Congress 2025, we shared translational data illustrating a mechanism of greater potency with #Verekitug, a novel antibody antagonist of the TSLP receptor, currently in development for the treatment of severe #asthma, #COPD & #CRSwNP. bit.ly/3SPlgJR
Heading to the @EAACI_HQ Annual Congress 2025 in Glasgow? Don’t miss our poster on Sunday, June 15, highlighting mechanistic insights into #Verekitug’s enhanced potency via TSLP receptor targeting. Learn more: bit.ly/3HIV2pK
Join us today at the @GoldmanSachs 46th Annual Global Healthcare Conference where our CEO, Rand Sutherland, MD, is participating in a fireside chat at 9:20 a.m. ET. Join here: bit.ly/3SMix3F#GoldmanSachs#UpstreamBio
Excited to share insights from our upcoming presentation at @EAACI_HQ on mechanistic insights into the differentiated mechanism of #verekitug, our investigational therapy for serious respiratory disorders targeting the TSLP receptor pathway. Learn more: bit.ly/3HIV2pK#EAACI2…
2K Followers 902 FollowingStocks, private equity, economics, and international politics. Personal views only.
P.S. Don't follow my investment ideas, my investments lose money regularly.
346 Followers 1K FollowingPostdoctoral scientist at the Max Planck Institute for Infection Biology. Interested in innate immunity, lipids and host-pathogen interactions.
189 Followers 235 FollowingUniversity of South Alabama Alumni ~ Nursing Graduate | Former Drag Race Facility Owner-CEO | Currently focused on AI Healthcare Solutions
5K Followers 3K FollowingDe Hidrogeólogo a Inversor ¡Aportando Valor a la Comunidad Inversora! “ 💰📈 ¡Actualidad de los Mercados Financieros - Análisis de empresas!
167 Followers 5K FollowingI am focused on capital introductions, fund launches, capital raises, relationship management, Institutional sales and marketing.
9K Followers 871 FollowingEAACI is a scientific association dedicated to improving the health of people affected by allergic diseases.
Website: https://t.co/2fiZIyAXsM
16K Followers 113 FollowingThe American Academy of Allergy, Asthma & Immunology consists of medical professionals devoted to optimal patient care in allergy, asthma and immunology.
721 Followers 537 FollowingThe Asthma and Allergy Foundation is a charity dedicated to improving the quality of life and health for people living with asthma and allergy.
524 Followers 289 FollowingCEO, President, Cofounder @Seismic_Tx | Supporter of #womeninstem @WESTorg and #communityphilanthropy @LS_Cares | Devoted dance mom | Fan of live theater
13K Followers 943 FollowingI help biopharma leaders & investors build cross-border relationships in the U.S., Europe, and Asia. Retweets are not endorsements.
279 Followers 613 FollowingLeads @TrophicComms, @FKHealth alumna, 20+ years as strategic communicator for global biopharma industry, always asking the #Gretchenfrage
1K Followers 3K FollowingCareer life sci marketer artist passionate about sci tech advancements that benefit humanity #AI #biotech #healthcare, #glio sucks pic is my late bro luv #golf
367 Followers 3K FollowingImproving human health with a keyboard. Creator of https://t.co/75sw7D1WGD: modular & interactive analysis tools for genomics in #rstats. Ghana #RPCV. Amateur Dad.
25K Followers 769 FollowingScientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player, #immigrant. CEO @ArrakisTx. Just @gilman on...
416 Followers 790 FollowingWriter, raconteur, maker of new things. My book of essays won the International Beverly Prize for Literature sponsored by Eyewear/Black Spring in the U.K.
20.9M Followers 1K FollowingSign up for our newsletters and alerts: https://t.co/QevH0DLQi8 | Got a tip? https://t.co/iXIigdPjEZ | For WSJ customer support: https://t.co/DZgH9n53qg
4K Followers 838 FollowingSenior Science Correspondent for @Endpts covering biotech, drug discovery, gene editing, RNA, and more. Formerly at Boston Globe and C&EN. Signal: RyanCross.25
3K Followers 662 FollowingCovering life sciences at @BosBizJournal. More often found at @rowanwalrath. Fully vaxed, for planning purposes. she/her. [email protected]
3K Followers 735 FollowingSofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability.
42K Followers 490 FollowingWe cover venture capital and the global startup ecosystem. WSJ Pro Venture Capital is a premium service of @wsj. News tips: [email protected]
74K Followers 25K FollowingThe Boston region's source for local business news & events. Part of the American City Business Journals network. Subscribe today! https://t.co/I8dEe5inYZ